Mark Clement

Chief Operating Officer at Revitope Oncology

Mark has nearly 30 years’ of experience in Biotechnology companies as a CBO, CFO and COO, leading private and public companies within Europe and the US. Mark has grown a number of companies from start up through IPO and trade sale, and has additional, extensive experience structuring and managing successful deals with world leading Pharmaceutical and Biopharmaceutical companies. He is a Chartered Accountant having qualified with PWC in London and has an MBA from Durham University and INSEAD.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Revitope Oncology

Revitope Oncology is a biotech company leveraging biological insights and protein engineering to develop a new class of cancer immunotherapies powered for precision.


Industries

Employees

11-50

Links